Sponsors (2)
States findings and context about the 2024 U.S. opioid/fentanyl overdose crisis, documenting deaths, potency, seizures, production sources, and demographic impacts.
The bill increases attention to fentanyl's lethal risk and could strengthen prevention, testing, and enforcement coordination, but it also risks steering resources toward punitive border and law-enforcement responses and fueling fear that may undercut treatment, harm reduction, and civil liberties.
People at risk of accidental fentanyl exposure (including people who use drugs and bystanders) could see wider support for naloxone distribution and fentanyl-testing resources because the bill highlights fentanyl's extreme potency and tiny lethal dose.
Adults aged 18–45 may benefit from more targeted prevention and treatment efforts because the bill emphasizes that fentanyl is a leading cause of death in this age group.
Law enforcement and public health agencies could coordinate better on interdiction and prevention because the bill increases emphasis on overdose data and chemical sourcing.
Taxpayers and people seeking treatment could see resources shifted toward enforcement rather than treatment and harm-reduction services because the bill emphasizes criminal-supply origins and large seizures.
Border communities and taxpayers could face higher enforcement costs and disruptions to cross-border trade if the bill's attribution of production to foreign sources increases pressure for tougher border measures.
The general public and civil-rights advocates may experience increased support for punitive policies and surveillance because the bill uses alarming seizure statistics that could heighten fear rather than promote public-health approaches.
Based on analysis of 2 sections of legislative text.
States findings about the U.S. opioid and fentanyl overdose crisis, documenting overdose deaths, fentanyl potency and lethality, large law-enforcement seizures, the role of counterfeit pills and drug contamination, production sources, and rising death rates among older adults. The resolution presents data and context to highlight the scope and severity of fentanyl-related poisonings as a public-health and law-enforcement priority.
Official title: Expressing support for the designation of February 23, 2025, to March 1, 2025, as "National Fentanyl Awareness Week" and raising awareness of the negative impacts of fentanyl in the United States.
Introduced February 25, 2025 by Richard Lynn Scott · Last progress February 25, 2025